Verano Announces Third Quarter 2024 Financial Results

In This Article:

Verano Holdings Corp.
Verano Holdings Corp.

CHICAGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the third quarter ended September 30, 2024, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).

Third Quarter 2024 Financial Highlights

 

 

For the Three Months Ended,

 

($ in thousands)

 

September 30, 2024

 

 

June 30, 2024

 

 

September 30, 2023

 

Revenues, net of Discounts

 

$

216,683

 

 

$

222,390

 

 

$

240,088

 

Gross Profit

 

 

109,097

 

 

 

114,340

 

 

 

133,220

 

Income from Operations

 

 

16,770

 

 

 

27,266

 

 

 

40,288

 

Net Loss Attributable to Verano Holdings Corp. & Subsidiaries

 

 

(42,567

)

 

 

(21,764

)

 

 

(17,842

)

Adjusted EBITDA1

 

 

64,458

 

 

 

70,599

 

 

 

89,349

 


Third Quarter 2024 Financial Highlights

  • Revenues, net of discounts, of $217 million, a decrease of 2.6% versus the prior quarter.

  • Gross profit of $109 million or 50% of revenue.

  • SG&A expense of $92 million or 43% of revenue.

  • Net loss of $(43) million or (20)% of revenue.

  • Adjusted EBITDA1 of $64 million or 30% of revenue.

  • Net cash provided by operating activities of $30 million.

  • Capital expenditures of $57 million.

Management Commentary

“During this election season, for the first time in history, cannabis took center stage as a key bipartisan issue for both U.S. presidential candidates and millions of voters across the nation,” said George Archos, Verano founder, Chairman and Chief Executive Officer. “Despite the Amendment 3 outcome, it was encouraging to see the measure supported by a majority of Floridians with 56% voting in favor, and we remain optimistic on our growth prospects in the state and our ability to succeed in the current environment."

Archos concluded: "With rescheduling proceedings set to commence in December, and additional dispensary openings planned across multiple markets, we are prepared to leverage potential catalysts in the months and years ahead at the state and federal levels. Given his prior supportive comments, we look forward to working with President-elect Trump and his administration to advance the rescheduling process and much-needed reforms, including tax relief and SAFER banking.”

Third Quarter 2024 Financial Overview

Revenue for the third quarter 2024 was $217 million, down from $240 million for the third quarter 2023, and down from $222 million for the second quarter 2024. The decrease in revenue for the third quarter 2024 compared to the third quarter 2023 was driven primarily by declines in Florida retail due to a temporary shift in cultivation output, in addition to expected declines in Illinois and New Jersey retail as dispensaries continue to open across the state.